首页> The Journal of clinical psychiatry> Earlier Use of Long-Acting Injectable Paliperidone Palmitate Versus Oral Antipsychotics in Patients With Schizophrenia: An Integrated Patient-Level Post Hoc Analysis.

Earlier Use of Long-Acting Injectable Paliperidone Palmitate Versus Oral Antipsychotics in Patients With Schizophrenia: An Integrated Patient-Level Post Hoc Analysis.

导出原文传递

翻译打印收藏纠错

第一作者： Oliver J,Lopena

第一单位： Janssen Scientific Affairs, LLC, Titusville, New Jersey.;Corresponding Author: Oliver J. Lopena, PharmD, Janssen Scientific Affairs, LLC, 1125 Trenton-Harbourton Road, Titusville, NJ 08560 (olopena@its.jnj.com).

作者： Oliver J,Lopena ^[1] ; Larry D,Alphs ^[2] ; Martha,Sajatovic ^[3] ; Ibrahim,Turkoz ^[4] ; Liping,Sun ^[5] ; Karen L,Johnston ^[6] ; Jennifer K,Sliwa ^[6] ; Dean M,Najarian ^[6] ; H Lynn,Starr ^[2]

作者单位： Janssen Scientific Affairs, LLC, Titusville, New Jersey.;Corresponding Author: Oliver J. Lopena, PharmD, Janssen Scientific Affairs, LLC, 1125 Trenton-Harbourton Road, Titusville, NJ 08560 (olopena@its.jnj.com). ^[1] Janssen Scientific Affairs, LLC, Titusville, New Jersey.;Drs Alphs and Starr were employees of Janssen Scientific Affairs, LLC, at the time studies were conducted. ^[2] Neurological and Behavioral Outcomes Center, University Hospitals of Cleveland Medical Center, Case Western Reserve University School of Medicine and University Hospitals of Cleveland, Cleveland, Ohio. ^[3] Janssen Research & Development, LLC, Titusville, New Jersey. ^[4] Cytel, Cambridge, Massachusetts. ^[5] Janssen Scientific Affairs, LLC, Titusville, New Jersey. ^[6]